Author(s): Antonioli L, Fornai M, Colucci R, Ghisu N, Tuccori M, et al.
Inflammatory bowel diseases (IBDs) are chronic disorders resulting from abnormal and persistent immune responses which lead to severe tissue injury and disturbances in digestive motor/secretory functions. At present, pharmacotherapy represents the cornerstone for the management of IBDs, and recent advances in understanding the immunopathogenesis of intestinal inflammation suggest the adenosine system as an attractive target for development of novel drugs against gut inflammatory disorders. Consistent evidence indicates that adenosine plays a relevant role in the regulation of immune system via interaction with specific cell-membrane G-protein-coupled receptors (A(1), A(2a), A(2b), and A(3)). Moreover, this nucleoside is implicated in the control of enteric neurotransmission and gut motor functions. In the presence of inflammation, the adenosine system acts as a sensible sensor apparatus, which, through dynamic modifications in the expression of ecto-enzymes and purinergic receptors, adapts its metabolism to tissue health status and contributes to the mechanisms deputed to the protection of tissues against inflammatory injuries. In keeping with these concepts, it is becoming increasingly appreciated that drugs targeted on adenosine receptors or enzymes responsible for adenosine catabolism can exert beneficial effects on experimental models of intestinal inflammation. This review aims to discuss the role of adenosine in the regulation of enteric immune responses and gut neuromuscular functions in the presence of inflammation, as well as to highlight the mechanisms through which the pharmacological modulation of adenosine pathways may have potential applications for the therapeutic management of IBDs.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/18022872
Author(s): Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, et al.
Author(s): Lee MY, Griendling KK
Author(s): Paravicini TM, Touyz RM
Author(s): Touyz RM
Author(s): De Artinano AA, Gonzalez VL
Author(s): Török J
Author(s): Kunes J, Hojná S, Kadlecová M, Dobesová Z, Rauchová H, et al.
Author(s): Richards TR, Tobe SW2
Author(s): Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, et al.
Author(s): Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, et al.
Author(s): Kumar N, Calhoun DA, Dudenbostel T
Author(s): Fredholm BB
Author(s): Del Ry S, Cabiati M, Lionetti V, Aquaro GD, Martino A, et al.
Author(s): Müller CE, Jacobson KA
Author(s): Eltzschig HK
Author(s): Johansson SM, Yang JN, Lindgren E, Fredholm BB
Author(s): Grenz A, Bauerle JD, Dalton JH, Ridyard D, Badulak A, et al.
Author(s): Sun D, Samuelson LC, Yang T, Huang Y, Paliege A, et al.
Author(s): Rosenberger P, Schwab JM, Mirakaj V, Masekowsky E, Mager A, et al.
Author(s): Huang ZL, Qu WM, Eguchi N, Chen JF, Schwarzschild MA, et al.
Author(s): Lazarus M, Shen HY, Cherasse Y, Qu WM, Huang ZL, et al.
Author(s): Liu XL, Zhou R, Pan QQ, Jia XL, Gao WN, et al.
Author(s): Haskó G, Linden J, Cronstein B, Pacher P
Author(s): Eltzschig HK, Eckle T
Author(s): Zhou Y, Schneider DJ, Blackburn MR
Author(s): Haskó G, Cronstein BN
Author(s): Caruso M, Alamo A, Crisafulli E, Raciti C, Fisichella A, et al.
Author(s): Karmouty-Quintana H, Xia Y, Blackburn MR
Author(s): Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, et al.